FDA’s 2023 approvals ended up not without the need of controversy, and some stats paint a much less dazzling image....
Drug
Evommune will leverage Accutar's AI-empowered drug discovery system for therapies focusing on persistent inflammatory health conditions PALO ALTO, Calif. and...
Dublin, July 04, 2023 (GLOBE NEWSWIRE) -- The "Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems" report has been...
